Tau-targeted treatment strategies in Alzheimer's disease

Pharmacology, Toxicology and Pharmaceutical Science

• Alzheimer's Disease 100%
• Amyloid Plaque 20%
• Amyloid Protein 20%
• Cholinergic Receptor Stimulating Agent 20%
• Cholinesterase Inhibitor 20%
• Degenerative Disease 20%
• Diseases 40%
• Excitotoxicity 20%
• Memantine 20%
• N Methyl Dextro Aspartic Acid Receptor Blocking Agent 20%
• Neurofibrillary Tangle 20%
• Peptide 20%
• Tau Protein 20%
• Vaccination 20%
• Virus Infection 20%

Neuroscience

• Acetylcholinesterase Inhibitor 20%
• Alzheimer's Disease 100%
• Amyloid Protein 40%
• Cholinergic 20%
• Excitotoxicity 20%
• Memantine 20%
• Nervous System Cell 20%
• Neurodegenerative Disorder 20%
• Neurofibrillary Tangle 20%
• NMDA Receptor Antagonist 20%
• Peptide 20%
• Plaque 20%
• Protein Aggregation 20%
• Tau Protein 20%

Veterinary Science and Veterinary Medicine

• Brain Disease 33%
• Cholinergic Neuron 16%
• Diseases 100%
• Mouse 33%
• Virus Infection 16%